235 related articles for article (PubMed ID: 30146732)
1. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
Woodruff MJ; Heading KL; Bennett P
Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
[TBL] [Abstract][Full Text] [Related]
2. Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam.
Langova V; Mutsaers AJ; Phillips B; Straw R
Aust Vet J; 2004 Nov; 82(11):676-80. PubMed ID: 15977611
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
[TBL] [Abstract][Full Text] [Related]
5. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
de Vos J; Ramos Vega S; Noorman E; de Vos P
Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
[TBL] [Abstract][Full Text] [Related]
6. [Combined palliative hypofractionated radiation and carboplatin chemotherapy of intranasal tumours in dogs].
Schwietzer A; Kessler M; Kandel-Tschiederer B
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Oct; 40(5):333-40. PubMed ID: 23076017
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
[TBL] [Abstract][Full Text] [Related]
8. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011).
Sones E; Smith A; Schleis S; Brawner W; Almond G; Taylor K; Haney S; Wypij J; Keyerleber M; Arthur J; Hamilton T; Lawrence J; Gieger T; Sellon R; Wright Z
Vet Radiol Ultrasound; 2013; 54(2):194-201. PubMed ID: 23278974
[TBL] [Abstract][Full Text] [Related]
9. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
Wouda RM; Hocker SE; Higginbotham ML
Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
11. Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study.
Barrett LE; Gardner HL; Barber LG; Sadowski A; London CA
BMC Vet Res; 2019 Aug; 15(1):291. PubMed ID: 31409327
[TBL] [Abstract][Full Text] [Related]
12. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
Robat C; Burton J; Thamm D; Vail D
J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
Bailey D; Erb H; Williams L; Ruslander D; Hauck M
J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
[TBL] [Abstract][Full Text] [Related]
14. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
[TBL] [Abstract][Full Text] [Related]
15. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
[TBL] [Abstract][Full Text] [Related]
16. Role of carboplatin in multi-modality treatment of canine tonsillar squamous cell carcinoma--a case series of five dogs.
Murphy S; Hayes A; Adams V; Maglennon G; Neath P; Ladlow J; Brearley MJ
J Small Anim Pract; 2006 Apr; 47(4):216-20. PubMed ID: 16573766
[TBL] [Abstract][Full Text] [Related]
17. OUTCOME OF DOGS WITH INTRANASAL LYMPHOMA TREATED WITH VARIOUS RADIATION AND CHEMOTHERAPY PROTOCOLS: 24 CASES.
George R; Smith A; Schleis S; Brawner W; Almond G; Kent M; Wypij J; Borrego J; Moore A; Keyerleber M; Kraiza S
Vet Radiol Ultrasound; 2016 May; 57(3):306-12. PubMed ID: 26763938
[TBL] [Abstract][Full Text] [Related]
18. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
Poirier VJ; Forrest LJ; Adams WM; Vail DM
J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
Cannon C; Borgatti A; Henson M; Husbands B
J Small Anim Pract; 2015 Jul; 56(7):425-9. PubMed ID: 25828786
[TBL] [Abstract][Full Text] [Related]
20. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
